Harvest Capital Strategies’s Accelerate Diagnostics AXDX Stock Holding History

Harvest Capital Strategies’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,000	Closed	-$2.15M	–	119
2015 Q4	$2.15M	Buy	10,000 +2,500	+33%	+$456K	0.29%	57
2015 Q3	$1.21M	Sell	7,500 -2,500	-25%	-$541K	0.22%	86
2015 Q2	$2.58M	Hold	10,000	–	–	0.33%	65
2015 Q1	$2.25M	Buy	10,000 +1,000	+11%	+$209K	0.2%	74
2014 Q4	$1.73M	Buy	+9,000	New	+$1.93M	0.19%	86
2014 Q2	–	Sell	-5,500	Closed	-$1.2M	–	123
2014 Q1	$1.2M	Sell	5,500 -6,500	-54%	-$963K	0.09%	114
2013 Q4	$1.46M	Buy	+12,000	New	+$1.6M	0.17%	96

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

MGM

Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Harvest Capital Strategies's AXDX Position: Q1 2016 in Review

Harvest Capital Strategies sold out of Accelerate Diagnostics (AXDX) in Q1 2016, closing a stake of 10,000 shares — an estimated $2.15M sold.

Harvest Capital Strategies first reported a position in AXDX in Q4 2013 and held it in 7 quarters. The position peaked at $2.58M in Q2 2015. 92 funds tracked by Wall St. Rank hold AXDX as of Q1 2016.

Harvest Capital Strategies reported no remaining Accelerate Diagnostics position as of Q1 2016 after selling out during the quarter.
Harvest Capital Strategies sold 10,000 Accelerate Diagnostics shares in Q1 2016, an estimated $2.15M.
Harvest Capital Strategies first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 7 quarters.
Harvest Capital Strategies's Accelerate Diagnostics position peaked at $2.58M in Q2 2015.
92 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2016.

Based on Harvest Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.